Asthma clinical trials

Explore recruiting asthma clinical trials.

Recruiting asthma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Asthma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b, Randomised, Double-Blind, Placebo Controlled Dose Range Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 Given Once Daily for 12 Weeks in Adults with Uncontrolled Asthma at Risk of Exacerbations (LEVANTE).

Germany, Spain, Italy, Slovakia, Netherlands, Czechia +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of dexpramipexole administered orally for 52 weeks in participants with severe eosinophilic asthma (EXHALE-3)

Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.

Poland, France, Slovakia, Spain, Hungary, Germany +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial of efficacy and safety with Dermatophagoides pteronyssinus and Dermatophagoides farinae mannan-conjugated allergoids in patients with rhinitis/rhinoconjunctivitis, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae _MM09-SIT-069

Portugal, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of dexpramipexole administered orally for 52 weeks in participants with severe eosinophilic asthma (EXHALE-3)

Czechia, Spain, Germany, Austria, Lithuania, Hungary +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma

Latvia, Hungary, Bulgaria, Romania, Portugal, Netherlands +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Asthma trials by city

Asthma in Toronto Asthma in Vancouver Asthma in Montreal Asthma in Calgary Asthma in Edmonton Asthma in Ottawa Asthma in Winnipeg Asthma in Quebec City Asthma in Hamilton Asthma in Kitchener Asthma in London Asthma in Halifax Asthma in New York Asthma in Los Angeles Asthma in Chicago Asthma in Houston

Other conditions

Depression Anxiety Bipolar disorder Schizophrenia PTSD OCD ADHD Insomnia Postpartum depression Alcohol use disorder Substance use disorder COPD Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea Chronic cough Crohn's disease Ulcerative colitis Irritable bowel syndrome Celiac disease GERD Eosinophilic esophagitis Gastroparesis